Ortho Clinical Diagnostics Hits the Road with Interactive, Cross-Country Tour of XT Mobile Experience Center

Ortho Clinical Diagnostics Hits the Road with Interactive, Cross-Country Tour of XT Mobile Experience Center

Jan 30, 2019

Tour Brings Ortho's VITROS® XT 7600 Integrated System, Among Other Innovations in Diagnostics, to Laboratories Across the U.S.

RARITAN, N.J. -- Ortho Clinical Diagnostics today announced the debut of its newly developed, state-of-the-art XT Mobile Experience Center and the kickoff of a 46-week tour of United States labs and hospitals. Dubbed the Ortho neXT Tour, the 18-wheeled mobile experience center is designed to demonstrate Ortho's newest offerings for the clinical lab.  Among other new technology, the Ortho neXT Tour will feature Ortho's next-generation analyzer, the VITROS XT® 7600 Integrated System, which was launched in 2018.

"Through the Ortho neXT Tour, we're thrilled to bring the latest in clinical lab technology right to the front doors of labs across the country," said Michael Iskra, president, Ortho North America.  "Ortho continues to reimagine what's possible, and we're happy to enable our customers to immerse themselves in our latest innovations and prepare for what's next without a significant interruption to their vital work."

Ortho's VITROS XT 7600 Integrated System tests blood for diseases, conditions and substances. It combines Ortho's proprietary MicroSlide technology -- which, unlike competitors' offerings, does not require water to run – with sophisticated digital imaging, bringing digital chemistry to the clinical lab.  In addition, the VITROS® XT System offers the potential to simultaneously perform two diagnostic tests that are typically ordered together, such as cholesterol and triglycerides, increasing throughput without requiring an increase in the lab's footprint.

Clinical labs face pressure to perform increasing volumes of diagnostic tests, often in the face of staff shortages and shrinking hospital space for labsi. The Ortho neXT Tour makes it easier for busy lab professionals to experience the latest innovations in lab technology.

In addition to trying out Ortho's next-generation analyzer, visitors will have the chance to experience Ortho's other offerings for clinical labs and transfusion medicine, such as the market-leading ORTHO VISION® Analyzer, VITROS® Automation Solutions, and Informatics Solutions for data management, as well as the company's award-winning Ortho Care™ customer service and support.

Ortho's XT Mobile Experience Center will begin its journey in Huntington Beach, Calif., in January 2019 and travel across the United States throughout the year. For more information and to register, please visit Orthonexttour.com. To follow the tour, visit Ortho's LinkedIn, Twitter, Facebook and Instagram pages.

About Ortho Clinical Diagnostics

Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 125 countries and territories, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.

PR-04744

i http://clinchem.aaccjnls.org/content/61/2/322

Media Contact:
Joseph Contrino
1 908 218 8737
joseph.contrino@orthoclinicaldiagnostics.com

© Ortho Clinical Diagnostics 2019. Ortho Clinical Diagnostics, publishes this site and is solely responsible for its content. The availability of the products is subject to compliance with the regulatory requirements of each market.
${loading}